Compare TELA & XBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TELA | XBP |
|---|---|---|
| Founded | 2012 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Business Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 41.0M | 33.1M |
| IPO Year | 2019 | 2021 |
| Metric | TELA | XBP |
|---|---|---|
| Price | $0.65 | $2.91 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 1 |
| Target Price | $2.00 | ★ $5.00 |
| AVG Volume (30 Days) | ★ 159.7K | 19.9K |
| Earning Date | 05-12-2026 | 05-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 37.59 | ★ 183.67 |
| EPS | ★ N/A | N/A |
| Revenue | $80,275,000.00 | ★ $872,690,000.00 |
| Revenue This Year | $10.23 | $2.59 |
| Revenue Next Year | $14.26 | $5.75 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 15.84 | N/A |
| 52 Week Low | $0.50 | $0.41 |
| 52 Week High | $2.00 | $8.55 |
| Indicator | TELA | XBP |
|---|---|---|
| Relative Strength Index (RSI) | 38.15 | 48.01 |
| Support Level | $0.56 | $2.11 |
| Resistance Level | $0.97 | $3.00 |
| Average True Range (ATR) | 0.10 | 0.25 |
| MACD | -0.02 | -0.04 |
| Stochastic Oscillator | 5.71 | 37.57 |
TELA Bio Inc a commercial-stage medical technology company focused on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. Its growing product portfolio is purposefully designed to leverage the patient's natural healing response while minimizing long-term exposure to permanent synthetic materials. The company's OviTex portfolio consists of multiple product configurations intended to address various surgical procedures within hernia repair and abdominal wall reconstruction, including ventral, inguinal, and hiatal hernia repair.
XBP Global Holdings Inc is a multinational technology and services company that drives intelligent workflows for organizations. Through its proprietary platforms, agentic AI-driven automation, and domain expertise across industries and the public and private sectors, the firm enables its clients to entrust their digital transformations and workflows. The segments of the company are Applied Workflow Automation and Technology. The Applied Workflow Automation segment generates maximum revenue and provides services powered by intelligent, AI-enabled workflows that generate outcomes for client's systems, while the Technology segment focuses on the sale of recurring and perpetual software licenses, software maintenance and professional services, as well as hardware solutions and maintenance.